NEW DATE: September 29, 2023 | Divani Caravel (ILISSOS HALL)

Prescribing a Healthier Future for Greece

«Το ΕΣΥ είναι ήδη 40 ετών και πρέπει αλλάξει με τρία νέα χαρακτηριστικά: μικρότερα και πιο εξειδικευμένα τμήματα, εξατομικευμένες θεραπείες, και ασθενοκεντρική προσέγγιση». Με κεντρικό αυτό το συμπέρασμα από την ομιλία του Υφυπουργού Υγείας Μάριου Θεμιστοκλέους ολοκληρώθηκε στις 29 Σεπτεμβρίου ένα από τα μεγαλύτερα συνέδρια πολιτικής υγείας της χώρας μας, το Future of Healthcare in Greece, με κεντρικό θέμα: «Prescribing a Healthier Future», το οποίο διοργανώθηκε για 13η συνεχή χρονιά από τη BOUSSIAS Events με τη παρουσία περισσοτέρων από 180 συμμετεχόντων και 30 κορυφαίων ειδικών σε Ελλάδα και Ευρώπη.

Το συνέδριο φέτος, του οποίου κεντρικός συντονιστής ήταν ο Καθηγητής, Διευθυντής Εργαστηρίου Οικονομίας και Διοίκησης Υγείας, Πανεπιστήμιο Πειραιώς, Τμήμα Οικονομικών Επιστημών, Αθανάσιος Βοζίκης, εστίασε στις άμεσες λύσεις και προτάσεις που θα μας οδηγήσουν στην επόμενη μέρα και την επόμενη δεκαετία αλλά και στις αλλαγές που θα απαιτήσουν μετασχηματισμό σε κάθε τμήμα του υπάρχοντος συστήματος υγειονομικής περίθαλψης και τη ραγδαία επιρροή της τεχνολογικής και ψηφιακής ανάπτυξης με ιδιαίτερη έμφαση στη χρήση και διάθεση των δεδομένων υγείας προκειμένου οι οποίες παρεμβάσεις να είναι μετρήσιμες.


During the last 12 years, the conference has hosted 130 distinguished international speakers representing:

♦ World Health Organization ♦ World Bank ♦ European Commission ♦ OECD ♦ European Patients Forum ♦ United Nations High Commissioner ♦ EUCOPE ♦ EFPIA ♦ European Medicines Agency ♦ London School of Economics ♦ University of Cambridge ♦ City University ♦ SDA Bocconi School of Management ♦ University of Connecticut ♦ University College-London ♦ NOVA University of Lisbon

Every year the Conference is attended by 500 delegates, whereas the past 12 years it has attracted approx. 6.000 live viewers via our live-streaming service and the conference videos reached 55.000 views.




live viewers


video views

Key Sessions will focus on:

  • Health Care 2030: The Coming Transformation and Key Development Affecting the Future of Healthcare
  • The Role of Healthcare in the Economy over the next 4 years
  • Strengthening and Restructuring Primary and Secondary Healthcare in Greece: Challenges & Opportunities
  • Τhe Quality of Health Services in Greece: Challenges and Opportunities
  • Challenging the Status Quo on Medicines Policy in GR


Who should Attend?

  • Members of the Greek Parliament
  • Senior government officials
  • Representatives of healthcare institutions
  • Public and private health services providers
  • Financial and corporate organizations
  • Senior executives from health and pharma industries
  • Health economists
  • Health Policy experts
  • Doctors
  • Patient advocates & patient group representatives
  • Academics
  • Researchers
  • Journalists


Statements of Key Leads


Affidea is the largest provider of Primary Health Care services in Europe with activity in 15 countries. In Greece Affidea started its operation in 2005 with the aim to provide high quality health services to everyone. Affidea centers are certified according to the international standard ISO 9001 and the biopathological laboratories are accredited by the National Accreditation System (ESS) according to ISO 15189. Today Affidea operates via a nationwide network of diagnostic centers with premium medical standards, state-of-the-art equipment and highly trained medical staff doctors.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 70,000 employees worldwide. Learn more at

KALTEQ SA with 20-year of presence in the Greek & Cypriot Market is continuously growing and stands out as a strong partner.

KALTEQ SA portfolio includes a huge variety of high standards medical products and instruments for General & Laparoscopic Surgery, Cardiac Surgery, Neurosurgery, Neuroradiology, Chronic Pain, ENT, Home Healthcare, etc.

KALTEQ SA has main offices in Athens and branches in Thessaloniki, Heraklion, Patras and Nicosia and is also active in the countries of Southeast Europe and Balkans.

Takeda is the largest pharmaceutical company in Japan and has a strong presence in over 80 geographies across the world. With a history for over two and a half centuries, we focus on innovations that contribute to making a difference in people’s lives in our core therapeutic and business areas, including gastroenterology and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.


Under the Auspices

Media Partner

Media Sponsors

Official Publication

Contact us

Elena Panagi, T: 210 6617777 (ext. 185), M: +306945580556, E: [email protected]
Chrysoula Kordouli, Τ: 210 6617777 (ext. 204), M: +30 6946236795, E: [email protected]
Info & Content
Natalia Toubanaki, T: +30 210 6617 777 (ext. 289), M: +30 6947936708, E: [email protected]

Boussias Events